Issuer · CIK 0001855175

CTNM — Contineum Therapeutics, Inc.

Recent filings

Mar 2, 2026·Form 4·Sell$62.6K
CTNM/Contineum Therapeutics, Inc.
Lorrain Daniel S. · Chief Scientific Officer
28conviction
Feb 13, 2026·Form 4·Sell$6.4K
CTNM/Contineum Therapeutics, Inc.
Lorrain Daniel S. · Chief Scientific Officer
8conviction

← Back to all filings